A detailed history of Triasima Portfolio Management Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Triasima Portfolio Management Inc. holds 32,974 shares of NVO stock, worth $2.93 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares
32,974
Previous 62,772 47.47%
Holding current value
$2.93 Million
Previous $8.96 Million 56.18%
% of portfolio
1.02%
Previous 0.99%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $3.55 Million - $4.33 Million
-29,798 Reduced 47.47%
32,974 $3.93 Million
Q2 2024

Aug 06, 2024

SELL
$122.71 - $146.91 $8,466 - $10,136
-69 Reduced 0.11%
62,772 $8.96 Million
Q1 2024

Apr 26, 2024

SELL
$102.11 - $135.92 $349,930 - $465,797
-3,427 Reduced 5.17%
62,841 $8.07 Million
Q4 2023

Jan 29, 2024

SELL
$87.78 - $105.45 $191,009 - $229,459
-2,176 Reduced 3.18%
66,268 $6.86 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $3.07 Million - $6.74 Million
33,768 Added 97.38%
68,444 $6.22 Million
Q2 2023

Aug 07, 2023

SELL
$155.98 - $172.65 $245,824 - $272,096
-1,576 Reduced 4.35%
34,676 $5.61 Million
Q1 2023

Apr 28, 2023

BUY
$132.34 - $159.14 $219,419 - $263,854
1,658 Added 4.79%
36,252 $5.77 Million
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $3.55 Million - $4.68 Million
34,594 New
34,594 $4.68 Million
Q3 2022

Mar 10, 2023

SELL
$95.28 - $116.93 $1.32 Million - $1.62 Million
-13,885 Reduced 27.26%
37,043 $3.69 Million
Q2 2022

Mar 10, 2023

SELL
$103.24 - $121.81 $111,499 - $131,554
-1,080 Reduced 2.08%
50,928 $5.68 Million
Q1 2022

Mar 10, 2023

BUY
$93.1 - $112.54 $1.62 Million - $1.96 Million
17,414 Added 50.34%
52,008 $5.78 Million
Q4 2021

Mar 10, 2023

BUY
$95.88 - $117.08 $382,561 - $467,149
3,990 Added 8.05%
53,538 $6 Million
Q3 2021

Mar 10, 2023

BUY
$84.42 - $106.62 $899,748 - $1.14 Million
10,658 Added 27.41%
49,548 $4.76 Million
Q2 2021

Mar 10, 2023

BUY
$67.66 - $84.76 $1.19 Million - $1.49 Million
17,600 Added 82.67%
38,890 $3.26 Million
Q1 2021

Mar 10, 2023

BUY
$67.06 - $75.82 $502,950 - $568,650
7,500 Added 54.39%
21,290 $1.44 Million
Q4 2020

Mar 10, 2023

SELL
$63.89 - $73.8 $1.33 Million - $1.54 Million
-20,804 Reduced 60.14%
13,790 $963,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Triasima Portfolio Management Inc. Portfolio

Follow Triasima Portfolio Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triasima Portfolio Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Triasima Portfolio Management Inc. with notifications on news.